Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Proximal Occlusion Systems, Distal Occlusion Systems, Distal Filters), By Application, By Region, And Segment Forecasts, 2025 - 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,950	100 Pages	Grand View Research	January, 2025	GV19584350

Best Price Guarantee
Price	from $5,950
Length	100 Pages
Publisher	Grand View Research
Published Date	January, 2025
SKU	GV19584350

Table of Contents
Description

Embolic Protection Devices Market Growth & Trends

The global embolic protection devices market size is expected to reach USD 1.1 billion in 2030 and is projected to grow at a CAGR of 8.9% from 2025 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

n the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Embolic Protection Devices Market Report Highlights

Distal filters accounted for the largest share of 48.0% in 2024 due to their ability to offer efficient protection against embolization during interventional procedures
Cardiovascular diseases held the highest revenue share of 43.1% in 2024
Neurovascular diseases are projected to grow at a CAGR of 7.9% over the forecast period
The growing preference for minimally invasive surgical techniques has further bolstered market dynamics.
North America embolic protection devices market dominated the global market with a revenue share of 29.1% in 2024.

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.2. Segment Definitions; 1.2.1. Product; 1.2.2. Application; 1.3. Estimates and Forecast Timeline; 1.4. Research Methodology; 1.5. Information Procurement; 1.5.1. Purchased Database; 1.5.2. GVR’s Internal Database; 1.5.3. Secondary Sources; 1.5.4. Primary Research; 1.6. Information Analysis; 1.6.1. Data Analysis Models; 1.7. Market Formulation & Data Visualization; 1.8. Model Details; 1.8.1. Commodity Flow Analysis; 1.9. List of Secondary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Snapshot; 2.2. Segment Snapshot; 2.3. Competitive Landscape Snapshot
Chapter 3. Embolic Protection Devices Market Variables, Trends, & Scope: 3.1. Market Lineage Outlook; 3.2. Market Dynamics; 3.2.1. Market Driver Analysis; 3.2.2. Market Restraint Analysis; 3.3. Business Environment Analysis; 3.3.1. Industry Analysis - Porter’s Five Forces Analysis; 3.3.1.1. Supplier Power; 3.3.1.2. Buyer Power; 3.3.1.3. Substitution Threat; 3.3.1.4. Threat of New Entrants; 3.3.1.5. Competitive Rivalry; 3.3.2. PESTLE Analysis
Chapter 4. Embolic Protection Devices Market: Product Business Analysis: 4.1. Product Market Share, 2024 & 2030; 4.2. Product Segment Dashboard; 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million); 4.4. Proximal Occlusion Systems; 4.4.1. Proximal Occlusion Systems Market, 2018 - 2030 (USD Million); 4.5. Distal Occlusion Systems; 4.5.1. Distal Occlusion Systems Market, 2018 - 2030 (USD Million); 4.6. Distal Filters; 4.6.1. Distal Filters Market, 2018 - 2030 (USD Million)
Chapter 5. Embolic Protection Devices Market: Application Business Analysis: 5.1. Application Market Share, 2024 & 2030; 5.2. Application Segment Dashboard; 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million); 5.4. Cardiovascular Diseases; 5.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million); 5.5. Neurovascular Diseases; 5.5.1. Neurovascular Diseases Market, 2018 - 2030 (USD Million); 5.6. Peripheral Diseases; 5.6.1. Peripheral Diseases Market, 2018 - 2030 (USD Million)
Chapter 6. Embolic Protection Devices Market: Regional Estimates & Trend Analysis: 6.1. Regional Market Share Analysis, 2024 & 2030; 6.2. Regional Market Dashboard; 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:; 6.4. North America; 6.4.1. North America Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million); 6.4.2. U.S.; 6.4.2.1. Key Country Dynamics; 6.4.2.2. Regulatory Framework; 6.4.2.3. Competitive Insights; 6.4.2.4. U.S. Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.4.3. Canada; 6.4.3.1. Key Country Dynamics; 6.4.3.2. Regulatory Framework; 6.4.3.3. Competitive Insights; 6.4.3.4. Canada Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.4.4. Mexico; 6.4.4.1. Key Country Dynamics; 6.4.4.2. Regulatory Framework; 6.4.4.3. Competitive Insights; 6.4.4.4. Mexico Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5. Europe; 6.5.1. Europe Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million); 6.5.2. UK; 6.5.2.1. Key Country Dynamics; 6.5.2.2. Regulatory Framework; 6.5.2.3. Competitive Insights; 6.5.2.4. UK Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.3. Germany; 6.5.3.1. Key Country Dynamics; 6.5.3.2. Regulatory Framework; 6.5.3.3. Competitive Insights; 6.5.3.4. Germany Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.4. France; 6.5.4.1. Key Country Dynamics; 6.5.4.2. Regulatory Framework; 6.5.4.3. Competitive Insights; 6.5.4.4. France Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.5. Italy; 6.5.5.1. Key Country Dynamics; 6.5.5.2. Regulatory Framework; 6.5.5.3. Competitive Insights; 6.5.5.4. Italy Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.6. Spain; 6.5.6.1. Key Country Dynamics; 6.5.6.2. Regulatory Framework; 6.5.6.3. Competitive Insights; 6.5.6.4. Spain Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.7. Norway; 6.5.7.1. Key Country Dynamics; 6.5.7.2. Regulatory Framework; 6.5.7.3. Competitive Insights; 6.5.7.4. Norway Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.8. Denmark; 6.5.8.1. Key Country Dynamics; 6.5.8.2. Regulatory Framework; 6.5.8.3. Competitive Insights; 6.5.8.4. Denmark Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.5.9. Sweden; 6.5.9.1. Key Country Dynamics; 6.5.9.2. Regulatory Framework; 6.5.9.3. Competitive Insights; 6.5.9.4. Sweden Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6. Asia Pacific; 6.6.1. Asia Pacific Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million); 6.6.2. Japan; 6.6.2.1. Key Country Dynamics; 6.6.2.2. Regulatory Framework; 6.6.2.3. Competitive Insights; 6.6.2.4. Japan Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6.3. China; 6.6.3.1. Key Country Dynamics; 6.6.3.2. Regulatory Framework; 6.6.3.3. Competitive Insights; 6.6.3.4. China Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6.4. India; 6.6.4.1. Key Country Dynamics; 6.6.4.2. Regulatory Framework; 6.6.4.3. Competitive Insights; 6.6.4.4. India Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6.5. South Korea; 6.6.5.1. Key Country Dynamics; 6.6.5.2. Regulatory Framework; 6.6.5.3. Competitive Insights; 6.6.5.4. South Korea Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6.6. Australia; 6.6.6.1. Key Country Dynamics; 6.6.6.2. Regulatory Framework; 6.6.6.3. Competitive Insights; 6.6.6.4. Australia Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.6.7. Thailand; 6.6.7.1. Key Country Dynamics; 6.6.7.2. Regulatory Framework; 6.6.7.3. Competitive Insights; 6.6.7.4. Thailand Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.7. Latin America; 6.7.1. Latin America Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million); 6.7.2. Brazil; 6.7.2.1. Key Country Dynamics; 6.7.2.2. Regulatory Framework; 6.7.2.3. Competitive Insights; 6.7.2.4. Brazil Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.7.3. Argentina; 6.7.3.1. Key Country Dynamics; 6.7.3.2. Regulatory Framework; 6.7.3.3. Competitive Insights; 6.7.3.4. Argentina Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.8. MEA; 6.8.1. MEA Embolic Protection Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million); 6.8.2. South Africa; 6.8.2.1. Key Country Dynamics; 6.8.2.2. Regulatory Framework; 6.8.2.3. Competitive Insights; 6.8.2.4. South Africa Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.8.3. Saudi Arabia; 6.8.3.1. Key Country Dynamics; 6.8.3.2. Regulatory Framework; 6.8.3.3. Competitive Insights; 6.8.3.4. Saudi Arabia Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.8.4. UAE; 6.8.4.1. Key Country Dynamics; 6.8.4.2. Regulatory Framework; 6.8.4.3. Competitive Insights; 6.8.4.4. UAE Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million); 6.8.5. Kuwait; 6.8.5.1. Key Country Dynamics; 6.8.5.2. Regulatory Framework; 6.8.5.3. Competitive Insights; 6.8.5.4. Kuwait Embolic Protection Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape: 7.1. Participant Overview; 7.2. Company Market Position Analysis; 7.3. Company Categorization; 7.4. Strategy Mapping; 7.5. Company Profiles/Listing; 7.5.1. Boston Scientific Corporation; 7.5.1.1. Overview; 7.5.1.2. Financial Performance; 7.5.1.3. Product Benchmarking; 7.5.1.4. Strategic Initiatives; 7.5.2. Edwards Lifesciences Corporation; 7.5.2.1. Overview; 7.5.2.2. Financial Performance; 7.5.2.3. Product Benchmarking; 7.5.2.4. Strategic Initiatives; 7.5.3. Abbott; 7.5.3.1. Overview; 7.5.3.2. Financial Performance; 7.5.3.3. Product Benchmarking; 7.5.3.4. Strategic Initiatives; 7.5.4. Medtronic; 7.5.4.1. Overview; 7.5.4.2. Financial Performance; 7.5.4.3. Product Benchmarking; 7.5.4.4. Strategic Initiatives; 7.5.5. Cardinal Health; 7.5.5.1. Overview; 7.5.5.2. Financial Performance; 7.5.5.3. Product Benchmarking; 7.5.5.4. Strategic Initiatives; 7.5.6. Innovative Cardiovascular Solutions, LLC; 7.5.6.1. Overview; 7.5.6.2. Financial Performance; 7.5.6.3. Product Benchmarking; 7.5.6.4. Strategic Initiatives; 7.5.7. Transverse Medical Inc.; 7.5.7.1. Overview; 7.5.7.2. Financial Performance; 7.5.7.3. Product Benchmarking; 7.5.7.4. Strategic Initiatives; 7.5.8. W. L. Gore & Associates, Inc.; 7.5.8.1. Overview; 7.5.8.2. Financial Performance; 7.5.8.3. Product Benchmarking; 7.5.8.4. Strategic Initiatives